This blog highlights the impact of living through a pandemic on mental health, including worsening substance abuse disorders, and on nutrition and access to primary health care.
CGD Policy Blogs
Accurately forecasting the demand for health products at health clinics, and ordering the correct quantity, is a significant challenge to ensuring availability of health products at the last mile of health systems. While much progress has been made since then in terms of more accurate global forecasting, clinic-level demand forecasts still remain an unaddressed area.
As the world battles COVID-19, practical investments are urgently needed to ensure that decision-makers consult the best and most relevant evidence on COVID-19 before making a decision.
COVID-19 Surfaces New Directions for Old Challenges: Three Lasting Ways to Improve Global Health Procurement
Effective and efficient procurement of health products—medicines, diagnostics, and devices—is a critical function of all strong health systems. The pandemic has exacerbated long-standing challenges—as highlighted by a recent CGD Working Group—in the purchasing of both COVID-related emergency supplies and other essential health products.
In a context where global cooperation is needed perhaps more than ever before, how concerned should we be by efforts to “stockpile” potential treatments, and how can we encourage further cooperation? We look at the case of dexamethasone and remdesivir.
With a population of 1.4 billion and very limited public funding for healthcare, how can the government of India ensure cost-effectiveness across their health scheme?
The authors look at the feasibility of the drug dexamethasone in low-income countries.
In this blog, we highlight reports of substantial long-term impacts of the COVID-19 response on health systems, ranging from government reductions in health spending to sharp decreases in utilisation of health services across health areas.
Following precedents applied first in wealthy states, more than 140 countries have applied some form of lockdown restrictions to slow their COVID-19 epidemics, but can control measures be made sustainable in low-income countries?
Last month, CGD and the Global Fund to Fight AIDS, Tuberculosis, and Malaria convened a high-level discussion, chaired by CGD President Masood Ahmed, to explore some of the rapidly evolving answers to these questions.